Daily Stock List
Keyuan Petrochemicals, Inc. (KEYP)
SmallCapVoice and TheStockAdvisors reported on Keyuan Petrochemicals, Inc. (KEYP), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.
Established in 2007, Keyuan Petrochemicals, Inc. is an independent manufacturer and supplier of various petrochemical products in the People’s Republic of China (PRC). The Company does this through its PRC operating subsidiaries, Ningbo Keyuan, Ningbo Keyuan Petrochemicals, Keyuan Synthetic Rubbers, and Guangxi Keyuan. Keyuan Petrochemicals commenced production in October of 2010.
The Company is based in Ningbo, Zhejiang Province, PRC. Keyuan Petrochemicals’ shares trade on the OTC Markets’ OTCQB. Keyuan’s management team consists of petrochemical experts with proven records of accomplishment from some of China's largest state-owned enterprises in the petrochemical industry.
Keyuan Petrochemicals’ operations include an annual petrochemical manufacturing design capacity of 720,000 MT for an array of petrochemical products. In addition, the Company completed the construction of a Styrene-Butadience-Styrene (the SBS) production facility with an annual production capacity of 70,000 MT in September 2011. One SBS production line started commercial production in December 2011. The second line started commercial production in August 2012.
Furthermore, Keyuan Petrochemicals’ operations include facilities for the storage and loading of raw materials and finished goods and manufacturing technologies that can support the Company’s manufacturing process with relatively low raw material costs and high utilization and yields.
Keyuan Petrochemicals, as of September 30, 2014, has invested roughly $110.9 million in the construction and improvement of its production facility. Its present production facility covers around 1.3 million square feet. This includes 594,000 square feet for production and 19,500 square feet for laboratories and offices. Additionally, the Company acquired the land use right of an additional 1.2 million square feet of land in August 2010 for its expansion.
Keyuan increased its total storage capacity from 100,000 MT to 134,000 MT in October 2014. This currently consists of 84,000 MT of storage capacity for raw materials and 50,000 MT for finished products. The Company’s intention is to add another 16,000 MT of new storage capacity in late 2015 to increase its total storage capacity to 150,000 MT, as a part of its expansion plan.
Keyuan Petrochemicals has an on-site ocean shipping dock with 5,000 MT of shipping capacity and a 10-truck loading facility. It also has adjacent access to another shipping dock with an additional shipping capacity of 50,000 MT. During the first three months of 2014, Keyuan started an application to the local government in Ningbo to upgrade the classification of its own dock so that the Company can unload foreign cargo vessels under the capacity of 50,000 MT to its dock directly. Keyuan expects that the upgrade will be completed and approved by the end of 2016 and will enable the Company to save additional logistics costs and storage fees.
Keyuan Petrochemicals, Inc. (KEYP), closed Thursday's trading session at $0.10, even for the day, on 8,700 volume with 1 trade. The average volume for the last 60 days is 20,705 and the stock's 52-week low/high is $0.0001/$1.25.
Quadrant 4 System Corp. (QFOR)
RedChip, WealthMakers, BUYINS.NET, PennyStockProphet, PennyStocks24, Planet Penny Stocks, Buzz Stocks, Stock Onion, SecretStockPromo, and Penny Pick Finders reported earlier on Quadrant 4 System Corp. (QFOR), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
A Vertical Cloud Platform company, Quadrant 4 System Corp. is a top Platform-as-a-Service (PaaS) and Software-as-a-Service (SaaS) company. It develops, implements, and operates PaaS and SaaS systems, including QHIX for the health insurance markets; QBLITZ for the digital media business; Education (QEDU), and qSKU for retailers. Quadrant 4 System lists on the OTCQB. The Company is based in Rolling Meadows, Illinois.
The platforms have a built in proprietary set of SMAC (social media, mobility, analytics and cloud computing) components and focus on providing solutions for Fortune 500 companies. The engineering of the Company’s PaaS solutions are for Internet scale traffic and built on this Social/Mobile/Analytics/Cloud (SMAC) architecture.
Quadrant 4 System’s platforms have a rich set of features and functionality. These include Responsive design, Mobility(Android iOS), Big Data Analytics(Hadoop based), NoSQL, Private-Public Cloud bursting, Security/Authentication/Single Sign-On, Social Modules(Social Graphs, Messaging, Gamification), Engagement(QR Codes, NFC, Beacons, Internet of Things Sensors), among numerous more.
Quadrant 4 System announced in 2014 that one of the largest insurance marketing organizations in Indiana, JA Benefits, LLC, selected the Company to develop its group and individual healthcare exchanges. A key driver behind JA Benefits selection of Quadrant 4 was the Company's U.S. Federally Facilitated Exchange Web Broker Entity (WBE) Agreement with the Centers for Medicare & Medicaid Services (CMS). It provides critical access to data that permits employees to quickly and easily determine eligibility status and enroll in government funded healthcare options.
Quadrant 4's proprietary Payment Gateway was also a critical element behind JA Benefits decision to adopt Quadrant 4's healthcare exchange technology. Quadrant 4’s Payment Gateway enables payroll deduction and direct pay capabilities.
Last month, Quadrant 4 System announced the signing and implementation of its QHIX Benefits Administration and Private Health Exchange capabilities for HealthSmart. HealthSmart will start deploying benefits and private health exchange capabilities for HealthSmart's over 1.2 million members nationwide. HealthSmart is the largest independent provider of managed care solutions for self-funded employers across the nation.
Quadrant 4 System Corp. (QFOR), closed Thursday's trading session at $0.655, up 5.65%, on 357,631 volume with 123 trades. The average volume for the last 60 days is 59,692 and the stock's 52-week low/high is $0.28/$0.786.
Arkados Group, Inc. (AKDS)
OTC Markets Group, TheMicrocapNews, Nebula Stocks, and CRWEWallStreet reported earlier on Arkados Group, Inc. (AKDS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed Arkados Group, Inc. is a leading software developer and system integrator enabling Internet of Things (IoT) applications. These applications are for home and building automation and energy management. Through using Arkados’ solutions, the Company’s customers can bring many state-of-the-art, full-featured products to market faster, at a lower overall development cost. The Company has its corporate headquarters in Newark, New Jersey.
The unique design of Arkados’ solutions are to drive a broad assortment of wireless and powerline communication (PLC)-based products. These include sensors, gateways, video cameras, appliances and other devices.
A leading software and hardware design company, Arkados focuses on developing solutions that enable machine to machine communications for the Internet of Things (IoT). It founded the HomePlug Powerline Alliance, an independent trade organization. This organization developed international specifications for high-speed powerline communications. It is the largest industry association in the space that encompasses companies such as Siemens, Cisco Systems, as well as Qualcomm.
Arkados Group’s solutions support smart grid and smart home applications chiefly in the areas of home and building automation and energy management. Its core technology is the Linq Universal Service Platform (LinqUSP). It is founded on making devices user-friendly and reliable throughout the life of the device.
This core technology serves as an underpinning to the Company’s overall device-specific software development activities. LinqUSP allows users to conduct initial provisioning of a device immediately out of the box to quickly get it up and running. It next monitors the health of the device to ensure continuous operation, with notifications made through cloud services.
Arkados Group has its wholly-owned subsidiary, Arkados Energy Solutions LLC (AES). AES is positioning itself as a global energy services provider. It is centering on the design, installation and maintenance of innovative, sustainable, and cost-effective energy solutions for residential and commercial customers.
Arkados Group signed a licensing agreement in 2014, via its wholly-owned subsidiary, Arkados, Inc., with Taiwan-based Tatung Co., for its proprietary Process and Event Management System for Smart Factory (PEMS-SF). PEMS-SF 1.0 is a cloud-based platform. It provides real-time status updates and two-way interactions throughout the entire life cycle of a production environment.
Recently, At the Smart City Expo '15, Tatung announced the availability of its full line of embedded modules developed specifically for use in different smart city applications. These include electrical vehicle charging, intelligent street lighting, and pervasive sensing & control. The design of the modules have been to suit applications requirements where system integration, standards-based communication protocols, reliability, and cost frequently arise as vital considerations in deployment. Tatung’s unveiling of a full line of embedded modules for smart city applications includes software support packages from Arkados Group.
Arkados Group, Inc. (AKDS), closed Thursday's trading session at $0.057, down 2.56%, on 750 volume with 1 trade. The average volume for the last 60 days is 89,975 and the stock's 52-week low/high is $0.01/$0.08.
Mechanical Technology, Inc. (MKTY)
SmarTrend Newsletters, PinnacleDigest, and RedChip reported earlier on Mechanical Technology, Inc. (MKTY), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Albany, New York-headquartered Mechanical Technology, Inc. engages in the design, manufacture and sale of test and measurement instruments and systems. These instrument and systems provide solutions for precision linear displacement, vibration measurement and balancing, and wafer inspection tools developed for markets that need the exacting measurement and control of products and processes in the development and implementation of automated manufacturing, assembly, and consistent operation of complex machinery. Mechanical Technology conducts its work via its wholly-owned subsidiary MTI Instruments, Inc. Mechanical Technology’s shares trade on the OTCQB.
MTI Instruments’ products use a total array of technologies to solve complex, real world applications in many industries. These industries include manufacturing, electronics, semiconductor, solar, commercial and military aviation, automotive, and data storage. MTI Instruments’ test and measurement segment has three product groups: Precision Instruments; Semiconductor and Solar Metrology Systems; and Balancing Systems.
Mechanical Technology operates in two segments. One is the Test and Measurement Instrumentation segment, which is conducted through the aforementioned MTI Instruments. The other is the New Energy segment, which is conducted through MTI MicroFuel Cells, Inc. (MTI Micro), a variable interest entity (VIE) as of September 30, 2013.
Pertaining to the New Energy Segment, until its operations were suspended in late 2011, MTI Micro had been developing an off-the-grid power solution for various portable electronic devices. Its patented, proprietary, direct methanol fuel cell (DMFC) technology platform, going by the name Mobion, converts methanol fuel to usable electricity capable of providing continuous power as long as required fuel flows are maintained.
MTI Micro continues to believe in the potential of its Mobion based power solutions. However, operations have been suspended at MTI Micro until market demand and other deciding factors, including obtaining additional external financing, the successful completion of customer trials, a new development program with a government agency, and/or a customer order come to fruition.
In April 2014, MTI Instruments announced that it received ISO 9001:2008 certification. This is a globally recognized standard issued to organizations with a quality management system.
Today, Mechanical Technology announced its 2014 results and business update. Selected highlights include operating income increasing by 56.5 percent versus the prior year as a direct result of increased sales and improved margins. Product revenue increased by 5.1 percent in 2014 versus 2013. This was because of increases in both instruments for automated manufacturing with new customers and engine vibration and balancing system activity under government contracts.
Gross profit, as a percentage of product revenue, increased to 62.6 percent in 2014 versus 61.0 percent in 2013. This was because of an improved product sales mix and reduced product costs attained with the Company’s lean manufacturing approach. The Company’s year-end backlog improved over the prior year by roughly $500,000 because of strong sales efforts in precision sensor instrumentations and systems.
Mechanical Technology, Inc. (MKTY), closed Thursday's trading session at $1.20, up 41.18%, on 75,112 volume with 71 trades. The average volume for the last 60 days is 5,466 and the stock's 52-week low/high is $0.6402/$1.83.
MRI Interventions, Inc. (MRIC)
Wall Street Resources reported earlier on MRI Interventions, Inc. (MRIC), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
MRI Interventions, Inc. is a medical device company. It develops and commercializes distinct platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI, guidance. Using a hospital's existing MRI suite, the design of its FDA-cleared and CE-marked ClearPoint® system is to enable a range of minimally invasive procedures in the brain. ClearPoint® is an integrated system of hardware components, disposable components, and intuitive, menu-driven software. MRI Interventions lists on the OTC Bulletin Board.
The Company has a co-development and co-distribution agreement with Brainlab, a leader in software-driven medical technology, relating to the ClearPoint® system. Furthermore, MRI Interventions is working with Boston Scientific to incorporate its MRI-safety technologies into Boston Scientific's implantable leads for cardiac and neurological applications.
The ClearPoint® system enables real-time MRI-guided navigation for a wide assortment of minimally-invasive neurosurgery procedures. The platform is especially well-suited for facilitating drug delivery directly to brain tumors. The ClearPoint® system provides MRI-based stereotactic guidance for the placement and operation of instruments or devices during the planning and operation of neurological procedures performed within the MRI suite. ClearPoint® procedures can be used with 1.5T and 3T scanners.
In addition, MRI Interventions is developing the ClearTrace® system in partnership with Siemens Healthcare. This is to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation.
MRI Interventions announced in August 2014 that neurosurgeons at UC San Diego Health System used the ClearPoint® system's platform capabilities to facilitate three same-setting MRI-guided neurosurgical procedures for a single patient. The team, led by Clark C. Chen, MD, PhD, Vice-Chairman of Academic Affairs for the Division of Neurosurgery at UC San Diego School of Medicine, biopsied a patient's brain tumor, aspirated a fluid-filled section of the tumor, and ablated the tumor. This was all under real-time MRI guidance enabled by the ClearPoint® system in the hospital's diagnostic MRI suite.
MRI Interventions will release financial results for its 2014 fourth quarter and full year ended December 31, 2014, today, Thursday, March 5, 2015, after the close of the U.S. financial markets.
MRI Interventions, Inc. (MRIC), closed Thursday's trading session at $0.83, up 3.75%, on 229,940 volume with 79 trades. The average volume for the last 60 days is 81,620 and the stock's 52-week low/high is $0.652/$1.42.
Payment Data Systems, Inc. (PYDS)
StockGuru, Nebula Stocks, AllPennyStocks, FeedBlitz, OTC Picks, MicrocapVoice, and OTCReporter reported on Payment Data Systems, Inc. (PYDS), and we also report on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed Payment Data Systems, Inc. is an integrated payment solutions provider to merchants and billers. The Company provides an extensive set of products to deliver world-class payment acceptance. It delivers its unique solutions by way of three separate but technically integrated companies. All of these are fully PCI/DSS certified Level One Processors and are wholly-owned subsidiaries of Payment Data Systems. Payment Data Systems has its head office in San Antonio, Texas.
The Company has solutions for merchants, billers, banks, service bureaus, and card issuers. Its strength is its ability to offer specifically tailored solutions for card issuance, payment acceptance, as well as bill payments.
Payment Data Systems focuses on the processing of payments for merchants and large enterprises. The design of its products are to provide payment solutions wherever a business’s customer happens to be or however they need to pay; by phone to a business’s Customer Service Department, at its website, by Interactive Voice Response (IVR), by retail terminal, or by mobile payments.
Payment Data Systems is acquiring largely all of the assets of Akimbo Financial, Inc. of San Antonio, Texas. The Company expects to complete the acquisition in the near future. The agreed purchase price is a total of $3 million. It is to be paid mainly in common stock in two tranches, with a cash component of up to $300,000 if any liabilities are assumed.
Last month, Payment Data Systems announced that it is continuing to experience high growth in transactions processed. January 2015's electronic check transaction volumes rose 22 percent and returned check transactions decreased 4 percent versus December 2014. It was the best month of electronic check processing in the history of Payment Data Systems.
Total dollars processed for January 2015 set a new record for the Company. They exceeded $302,000,000 and broke the prior record that was attained in December 2014. Credit cards dollars processed during January 2015 increased 9 percent over the same time period in 2014. Credit cards transactions processed during January 2015 increased 5 percent over the same time period in 2014.
Payment Data Systems, Inc. (PYDS), closed Thursday's trading session at $0.38, up 7.04%, on 745,773 volume with 141 trades. The average volume for the last 60 days is 126,057 and the stock's 52-week low/high is $0.061/$0.40.
Event Cardio Group, Inc. (ECGI)
SmallCapVoice reported last week on Event Cardio Group, Inc. (ECGI), StockHotTips and PennyTrader did previously, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Event Cardio Group, Inc. is a medical device company that lists on the OTCQB. The Company is a developer of medical diagnostic detection equipment, which focuses on the detection and preventive treatment of high-risk diseases. Event Cardio’s dedication is to providing life-enhancing, innovative medical products to the public via partnerships with non-profit organizations, corporations, academia, the government, as well as individuals. The Company has its headquarters in New York, New York.
Event Cardio Group operates in the cardiac medical device innovation, patient monitoring and cardiac event prediction industry. Its core products include its Now Cardio™, which is an advanced cardiac monitor that offers dual-functionality including holter monitoring and event recording simultaneously. Now Cardio™ is an innovative medical device designed by CONTEX International Technologies (Canada), Inc., a healthcare and aerospace high technology engineering company.
Event Cardio Group’s core products also include the Food and Drug Administration (FDA) approved BreastCare DTS™ breast cancer detection device. BreastCare DTS™ is a user-friendly, single-use device. BreastCare DTS™ has received FDA 510K clearance for marketing in the U.S. BreastCare DTS™ is a non-invasive device that enables women to safely and affordably screen for breast cancer throughout the year, in combination with annual or bi-annual mammography and clinical breast examination.
The patented device consists of two soft, disposable pads, which are lightweight and non-invasive. They are 98 percent accurate as an early detector of possible breast cancer. The BreastCare DTS™ device is not intended to replace mammography, ultrasound and other detection methods. It is to be used as an adjunct to these screening methods.
Last week, Event Cardio Group announced that it contracted Ceres Technologies, of Saugerties, New York, to engineer and manufacture BreastCare DTS™. Mechanical, electrical and chemical engineers at Ceres are completing design and execution plans for the first production units to be completed in the middle of this month. The marketing of BreastCare DTS™ is to be as an adjunct to mammography and other procedures for the detection of breast cancer.
Event Cardio Group, Inc. (ECGI), closed Thursday's trading session at $0.149, down 0.67%, on 120,651 volume with 27 trades. The average volume for the last 60 days is 25,955 and the stock's 52-week low/high is $0.02/$0.19.
VistaGen Therapeutics, Inc. (VSTA)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $8.00, up 14.29%, on 500 volume with 5 trades. The stock’s average daily volume over the past 60 days is 621, and its 52-week low/high is $3.16/$15.00.
VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
AV-101, VistaGen's lead small molecule prodrug candidate, has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
VistaGen and NIH Sign Agreement for NIH-Sponsored Phase 2 Study of Orally-Active AV-101 in Major Depressive Disorder
Dr. Gerard Sanacora Joins VistaGen's Clinical and Scientific Advisory Board
VistaGen Signs Letter of Intent With National Institute of Mental Health for NIH-Sponsored Phase 2 Clinical Study of AV-101 in Major Depressive Disorder
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.0625, up 5.93%, on 1,286,020 volume with 94 trades. The stock’s average daily volume over the past 60 days is 572,120, and its 52-week low/high is $0.0555/$0.255.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.
The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.
In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Announces Completion of Cell Bank for Parkinson's Disease Clinical Trial
International Stem Cell Corporation to Conduct Parkinson's Disease Clinical Study in Australia
International Stem Cell Corporation to Present at Biotech Showcase(TM) 2015
Well Power Inc. (WPWR)
The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.0379, up 6.46%, on 9,389 volume with 2 trades. The stock’s average daily volume over the past 60 days is 88,732, and its 52-week low/high is $0.03/$0.83.
Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.
The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.
Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.
Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer
Well Power Inc. Company Blog
Well Power Inc. News:
Well Power - Letter from President to Shareholders
Well Power Inc. to host second webinar on proprietory micro-refinery technology
Well Power Inc. Information to be Available through S&P Capital IQ Corporation Records Program
Resort Savers, Inc. (RSSV)
The QualityStocks Daily Newsletter would like to spotlight Resort Savers, Inc. (RSSV). Today, Resort Savers, Inc. closed trading at $0.547905, up 5.37%, on 6,275 volume with 6 trades. The stock’s average daily volume over the past 60 days is 24,897, and its 52-week low/high is $0.44/$0.60.
Resort Savers, Inc. (RSSV) has built its reputation as an innovative environmental energy engineering company with expert diagnostic abilities and a diversified line of patented products. The company’s acquisition model seeks to identify innovative and market-ready petroleum industry technologies for installation and distribution throughout the Greater China market.
RSSV also has exclusive China rights for Worx America’s proprietary environmental engineering technologies as well as a 20% pre-IPO equity option. The Worx automated robotic systems quickly clean oil tanks and recover clean oil from waste sludge, resulting in increased sales and cost savings. The Worx multiple line of products and services give RSSV the capacity to offer proprietary solutions for onshore, offshore and subsea oil production, refining, cleaning and reclamation.
RSSV’s goal is to rapidly gain market share in China’s under-served oil tank cleaning and sludge processing industries through Worx technologies and on-ground training and installation. Senior management of Worx has been working in the field at RSSV’s China operations and has developed a training program for top engineers to go to Houston for further training and on-site systems installation and operations.
The company is led by a solid management team, owns a growing line of proprietary market-specific systems, and has positioned itself well as a high margin, competitive company. With a global focus, RSSV continues to pursue strategic partnerships and the licensing of key technologies for its extensive and growing customer base. Disclaimer
Resort Savers, Inc. Company Blog
Resort Savers, Inc. News:
Resort Savers, Inc. Closes $2M Investment
Resort Savers, Inc. Closes $700,000 Investment in Worx America
Resort Savers, Inc. Announces $2 Million Investment to Acquire Worx America, Inc. Interest
Sparta Commercial Services, Inc. (SRCO)
The QualityStocks Daily Newsletter would like to spotlight Sparta Commercial Services, Inc. (SRCO). Today, Sparta Commercial Services, Inc. closed trading at $0.11, up 0.09%, on 7,245 volume with 5 trades. The stock’s average daily volume over the past 60 days is 97,729, and its 52-week low/high is $0.078/$1.34.
Sparta Commercial Services, Inc. (SRCO) is a New York-based technology company whose subsidiary, Specialty Reports, Inc., is a leader in developing, managing, and servicing custom mobile apps for small and medium sized businesses as well as for retail vehicle dealers, in addition to providing motor vehicle title history reports to dealers, insurance companies, financial institutions, consumers, and other interested parties. Sparta Commercial Services also offers and administers vehicle and capital equipment lease financing programs for municipalities.
iMobileApp.com develops and services customized mobile applications for powersports, automobile, recreation vehicle, marine, and agriculture equipment dealers as well as for racetracks, restaurants, liquor stores, schools and any other small to medium sized company. The iMobileApp allows businesses to stay in touch with their customers, to notify them of upcoming and ongoing promotions, special events, and provide them with the ability to view new and used inventory, communicate directly with the service department, and more. The mobile application is generated, packaged, and made available on-line, at no cost to the company's customers, through the Apple App Store and the Google Play Store.
The company also serves as a one-stop online source for various types of vehicle title history reports, including motorcycles, recreation vehicles, automobiles, light trucks, and commercial (heavy duty) trucks. Its online history report products include Cyclechex.com, a motorcycle vehicle title history report provider; RVchecks.com, a RV vehicle title history report provider; and CarVinReport.com, an automobile and light truck vehicle title history report provider, and TruckChex.com, a commercial (heavy duty) truck vehicle title history report provider.
In addition to consumers – both buyers and sellers – vehicle dealerships, insurance companies, financial institutions and others benefit from the information provided on these vehicle title history reports. The Specialty Reports, Inc. vehicle title history reports are featured online at NADAGuides.com, KBB.com and DMV.org, prominent online sources for pre-owned vehicle values and other important information for both buyers and sellers.
The company’s Municipal Lease Financing Program for local and/or state agencies throughout the country provides an economical way to finance essential equipment, from police motorcycles and cruisers to EMS equipment and busses, to virtually any type of equipment required. The lease purchase financing program receives considerable praise for its understanding of government acquisition procedures and its work with a wide range of vendors.
Sparta Commercial Services is an innovative and diversified company that has proven its ability to identify the needs and interests of its targeted markets, as well as develop products and services specifically designed to meet those needs and interests now and well into the future. With a full suite of offerings that address the challenges of the powersports, recreation, and auto industries, the company is well positioned to achieve strong future growth rates. Disclaimer
Sparta Commercial Services, Inc. Company Blog
Sparta Commercial Services, Inc. News:
Sparta Commercial Reports Continued Sales Growth
iMobileApp's Customer Base Continues to Grow and Broaden
Sparta Commercial Reports a Continuing Increase in Mobile App Sales
Falcon Crest Energy (FCEN)
The QualityStocks Daily Newsletter would like to spotlight Falcon Crest Energy (FCEN). Today, Falcon Crest Energy closed trading at $0.0159, even for the day. The stock’s average daily volume over the past 60 days is 9,596, and its 52-week low/high is $0.0066/$0.095.
Falcon Crest Energy (FCEN) is a development stage oil and gas exploration and production company focused on developing properties in North America. The company plans to minimize the risk of exploration through development of proved petroleum reserves, and expects to maximize profit through strategic acquisition and liquidation of selected oil and gas properties.
The company specializes in acquiring low risk, high upside properties with substantial exploration potential. Through improvements in oil and gas production technologies, Falcon Crest Energy aims to rapidly increase production levels and generate predictable, sustainable value. The business strategy utilized calls for both 100% acquisitions and joint-ventures to maximize production capacity.
Evergreen Petroleum, a joint venture partner, is working closely with the company to explore oil-bearing formations in Wyoming. Evergreen has conducted and will continue to conduct both regional and local geological studies to define prospects that are worthy of acquiring oil and gas leases. By partnering with industry experts such as Evergreen, Falcon Crest Energy has strategically added extensive technical guidance and field management experience.
Even during challenging times, the world depends on oil & gas exploration and production companies to deliver millions of barrels of oil every day. Increased demand from emerging countries such as China further escalates competition for this precious resource. Backed by an experienced group of professionals, Falcon Crest Energy is well positioned to generate substantial revenues in the short and long term future. Disclaimer
Falcon Crest Energy Company Blog
Falcon Crest Energy News:
Falcon Crest Energy Acquires Remaining Working Interest in Rocky Ford Field
Falcon Crest Names Michael Cvetanovic to Advisory Council
Falcon Crest Energy Announces Powder River Basin Leasehold Acquisition
eCareer Holdings, Inc. (ECHI)
The QualityStocks Daily Newsletter would like to spotlight eCareer Holdings, Inc. (ECHI). Today, eCareer Holdings, Inc. closed trading at $0.30, even for the day. The stock’s average daily volume over the past 60 days is 9,596 and its 52-week low/high is $0.0066/$0.095.
eCareer Holdings, Inc. (ECHI) is an early-stage internet company working to organize the online hiring process by creating content-rich, profession-specific communities. By fully integrating its personalized career centers with matching branded professional and social networks, the company creates a solution for employers and professionals to enjoy the very best user experience.
The company’s development of branded career websites focuses on specialized “Internet Job Verticals,” which allow for some of the most effective job advertising platforms on the market. Through the use of superior technological solutions, eCareer Holdings plans to address the high demand for skilled professionals in a variety of narrow sectors while simultaneously attracting potential clients with strong advertising budgets.
Headquartered in Boca Raton, Florida, eCareer Holdings launched its first site, Openreq™, in January 2013. Using advanced software solutions, the site provides staffing, recruiting and human resource professionals with access to job openings in their desired sector. With a single post to Openreq, companies can reach over 1,300 sites including popular social networking destinations such as Indeed, Glassdoor, Facebook and SimplyHired. The company is also currently developing Cardiologist.com and BioFuel Zone, which are planned for release in the near future.
Led by a team of experienced executives headed by Chief Executive Officer Joseph J. Azzata, eCareer Holdings is persistently working to refine its effective job database solutions. With a range of unique features including industry news, social media groups, webinars, events, training programs and consolidated industry statistics, eCareer Holdings continues to engage in the design and development of revolutionary career websites aimed at recruiters, staffing companies and government agencies. Disclaimer
eCareer Holdings, Inc. Blog
eCareer Holdings, Inc. News:
eCareer Holdings Reports 1000% Increase in Openreq.com Site Traffic, Seeks to Expand Salesforce
eCareer Announces Engagement of QualityStocks Investor Relations Services
eCareer Relaunches Openreq With Revolutionary Job Matching Technology
Today's Top 3
Center Stage Stocks
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Boreal Water Collection, Inc. (BRWC) Releases Open Letter to Shareholders
- Cleartronic, Inc. (CLRI) Announces Expanded License Agreement With Collabria LLC
- Coastal Integrated Services, Inc. (COLV) Announces Subsidiary's Nomination for Prestigious Award
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
- eCareer Holdings, Inc. (ECHI) Reports 1000% Increase in Openreq.com Site Traffic, Seeks to Expand Salesforce
- Falcon Crest Energy (FCEN) Acquires Remaining Working Interest in Rocky Ford Field
- IFAN Financial, Inc. (IFAN) Reaches Technology Development Milestones
- International Stem Cell Corp. (ISCO) Announces Completion of Cell Bank for Parkinson's Disease Clinical Trial
- MIT Holding, Inc. (MITD) Launches New Website with Investor Relations Suite
- Mobile Lads Corp. (MOBO) Purchases Majority of North American Shopping Network From Domark International
- One World Holdings, Inc. (OWOO) The One World Doll Project CEO Announces 2015 Revenue Projections in Stockholder Letter
- Pure Hospitality Solutions, Inc. (PNOW) anticipates $40 Million Oveedia Valuation with Divest and Focus Strategy
- Resort Savers, Inc. (RSSV) Closes $2M Investment
- Save The World Air, Inc. (ZERO) Deploys AOT(TM) Viscosity Reduction System on Condensate Pipeline in Eagle Ford
- Sibling Group Holdings, Inc. (SIBE) Urban Planet Mobile Announces Partnership for Writing Planet in Hong Kong Secondary Schools
- Sparta Commercial Services, Inc. (SRCO) Reports Continued Sales Growth
- Start Scientific, Inc. (STSC) Signs Farmout Agreement With Durban Energy
- VistaGen Therapeutics, Inc. (VSTA) and NIH Sign Agreement for NIH-Sponsored Phase 2 Study of Orally-Active AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) to host second webinar on proprietory micro-refinery technology
- Zenosense, Inc. (ZENO) Hospital Collaboration - 400 Person Lung Cancer Detection Trial